ASXL1 and myeloid neoplasm: Loss of Asxl1 was reported to lead to MDS-like disease in mice [41], whereas enforced overexpression of truncated forms of ASXL1 show gain-of-function and promote the pathogenesis of myeloid malignancies [129,130].